Passive Digital Phenotyping
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 36C10X25C0024
- Agency
-
VA Strategic Acquisition Center Frederick
Headquarters, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36C10X25C0024 Federal contract award
- Awardee
- Behavidence, Inc.
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Place of performance
- New York, New York, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Strategic Acquisition Center Frederick has issued a Limited / Sole Source Justification Notice for a research study with Behavidence, Inc. to develop a mobile application using digital phenotyping to detect behavioral risk factors associated with suicide and PTSD in Veterans. The one-year contract (36C10X25C0024) will leverage the Behavidence app to passively monitor smartphone data and provide real-time mental health risk insights through a two-phase approach. Phase 1 will focus on validating digital phenotypes for high-risk suicide and PTSD profiles, while Phase 2 will conduct a field test to assess the solution's integration potential within VA services. The procurement was conducted through a Broad Agency Announcement, with the government determining Behavidence, Inc. as the sole contractor capable of meeting their specific requirements after extensive market research. The project aims to provide a proactive alternative to traditional mental health screenings by capturing subtle behavioral indicators and enabling timely intervention for at-risk veterans.
Notice text
Behavidence, Inc. in partnership with the Veterans Integrated Services Network (VISN) 4 Mental Illness Research Education and Clinical Center( MIRECC) at the Crescenz VA Medical Center shall conduct a VA Institutional Review Board (IRB) approved research study. Behavidence, Inc. shall provide expertise in the development and refinement of the Behavidence mobile application, which continuously detects behavioral risk factors associated with Suicide and Post-traumatic stress disorder (PTSD) in Veterans. The application data will be supplied to the VA for validation. The VISN 4 MIRECC will assist in regulatory compliance, recruitment, and consent of subjects, sending and collection of the patient-reported outcomes, and data analysis.
The Behavidence, Inc. shall introduce a passive monitoring solution through digital phenotyping that can continuously detect behavioral risk factors associated with suicide and PTSD in Veterans by utilizing non-intrusive smartphone data collected via the Behavidence app. The app provides real-time continuous monitoring of behavioral health symptoms passively and unobtrusively. Behavidence, Inc. shall validate and add measures of suicidal-related behavior and PTSD phenotypes specifically adapted to Veterans. This approach is a proactive alternative to traditional, episodic mental health screenings, offering continuous, real-time insights into mental health risk indicators and potentially identifying critical high-risk periods for timely intervention. Digital phenotyping captures subtle but crucial indicators of suicide risk, such as changes in social engagement and sleep patterns, providing an up-to-date and comprehensive picture of mental health regardless of engagement with VA services.
The primary outcomes of this project are fully validated phenotypes for clinical use, clinician-oriented reporting tools, and a field test report detailing usability, feedback, and outcome metrics. The report will cover clinician feedback, including insights on data integration, ease of interpretation, and practical application within VA clinical workflows. Additionally, the field test will document any modifications needed for full-scale deployment, assessing the feasibility of integrating continuous digital phenotyping within the VA to improve suicide prevention and PTSD monitoring outcomes. Testing shall be completed in a two-phase approach.
The primary deliverables for phase 1 will include validated digital phenotypes for high-risk suicide and PTSD profiles, along with documentation of the predictive accuracy and alignment with clinical standards. This documentation will detail the model's sensitivity, specificity, and overall performance when tested against clinical assessments. This phase will also produce preliminary reports on user engagement and clinician feedback, which will inform further adjustments in preparation for the Field Test/Pilot Phase 2.
Awarded contract 36C10X25C0024 to unknown vendor for unknown amount on 2025-05-19.
Files
| File | Type | Posted |
|---|---|---|
| J and A Digital Phenotyping PRINT_Redacted.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity